Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 31, 2024 (Week 35)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 12,650 35,402 916,407 1,128,840
New England 167 1,172 28,517 36,455
Connecticut 29 318 4,454 8,842
Maine 34 81 1,785 2,001
Massachusetts - 647 17,226 19,391
New Hampshire - 76 1,384 1,920
Rhode Island 85 389 2,818 3,379
Vermont 19 33 850 922
Middle Atlantic 2,740 4,379 122,879 135,361
New Jersey 411 769 19,941 24,470
New York (excluding New York City) 808 957 26,192 28,586
New York City 668 1,565 41,930 45,304
Pennsylvania 853 1,168 34,816 37,001
East North Central 1,612 4,704 107,146 154,830
Illinois 1 1,449 18,555 47,926
Indiana 368 698 20,592 23,458
Michigan 201 1,020 19,423 28,790
Ohio 661 1,153 32,945 37,708
Wisconsin 381 533 15,631 16,948
West North Central 430 2,118 58,072 66,291
Iowa 105 313 7,850 9,357
Kansas 144 304 7,948 9,178
Minnesota 84 486 13,167 14,796
Missouri - 718 18,915 21,031
Nebraska - 225 5,407 6,206
North Dakota 53 87 2,037 2,332
South Dakota 44 108 2,748 3,391
South Atlantic 2,453 12,281 226,750 259,073
Delaware - 227 3,168 3,808
District of Columbia 19 188 4,443 5,765
Florida - 6,934 71,203 76,393
Georgia - 1,501 41,377 49,983
Maryland 872 1,016 20,785 24,260
North Carolina 1 1,435 35,392 45,175
South Carolina 694 820 22,205 22,508
Virginia 833 912 25,415 28,194
West Virginia 34 116 2,762 2,987
East South Central 971 2,748 40,447 73,955
Alabama 577 889 21,410 22,913
Kentucky 280 592 10,483 11,074
Mississippi 114 1,006 8,554 13,827
Tennessee - 905 - 26,141
West South Central 757 4,645 130,871 154,716
Arkansas 180 399 10,346 12,361
Louisiana 387 774 22,340 25,042
Oklahoma 45 422 7,101 13,500
Texas 145 3,261 91,084 103,813
Mountain 733 2,691 64,806 79,083
Arizona 433 889 25,553 27,966
Colorado - 857 13,939 17,613
Idaho 54 127 3,414 3,956
Montana 50 98 2,216 2,463
Nevada 22 357 7,187 10,670
New Mexico 15 235 4,824 7,676
Utah 159 255 6,752 7,480
Wyoming - 47 921 1,259
Pacific 2,787 5,049 136,919 169,076
Alaska 33 125 3,202 3,517
California 2,115 3,945 112,716 131,617
Hawaii - 146 - 4,274
Oregon 261 352 9,339 10,417
Washington 378 609 11,662 19,251
U.S. Territories - 135 667 3,504
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 135 667 3,504
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 3 3 22 39
Total 12,653 35,446 917,096 1,132,383
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.